
Hien Thi Tran
Examiner (ID: 9609)
| Most Active Art Unit | 1764 |
| Art Unit(s) | 1764, 1312, 1801 |
| Total Applications | 1244 |
| Issued Applications | 852 |
| Pending Applications | 137 |
| Abandoned Applications | 255 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6689046
[patent_doc_number] => 20030032771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Peptide inhibitors of cellular proliferation'
[patent_app_type] => new
[patent_app_number] => 09/782816
[patent_app_country] => US
[patent_app_date] => 2001-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10620
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032771.pdf
[firstpage_image] =>[orig_patent_app_number] => 09782816
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/782816 | Peptide inhibitors of cellular proliferation | Feb 13, 2001 | Abandoned |
Array
(
[id] => 6720729
[patent_doc_number] => 20030054417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Epithelial protein lost in neoplasm (EPLIN)'
[patent_app_type] => new
[patent_app_number] => 09/783732
[patent_app_country] => US
[patent_app_date] => 2001-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 31780
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054417.pdf
[firstpage_image] =>[orig_patent_app_number] => 09783732
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/783732 | Epithelial protein lost in neoplasm (EPLIN) | Feb 12, 2001 | Abandoned |
Array
(
[id] => 6744596
[patent_doc_number] => 20030021779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers'
[patent_app_type] => new
[patent_app_number] => 09/782397
[patent_app_country] => US
[patent_app_date] => 2001-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 27738
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20030021779.pdf
[firstpage_image] =>[orig_patent_app_number] => 09782397
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/782397 | Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers | Feb 12, 2001 | Abandoned |
Array
(
[id] => 6356770
[patent_doc_number] => 20020058041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Kidney-specific tumor vaccine directed against kidney tumor antigen G-250'
[patent_app_type] => new
[patent_app_number] => 09/783708
[patent_app_country] => US
[patent_app_date] => 2001-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 22577
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058041.pdf
[firstpage_image] =>[orig_patent_app_number] => 09783708
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/783708 | Kidney-specific tumor vaccine directed against kidney tumor antigen G-250 | Feb 12, 2001 | Issued |
Array
(
[id] => 6519333
[patent_doc_number] => 20020192223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Novel antibody conjugates reactive with human carcinomas'
[patent_app_type] => new
[patent_app_number] => 09/782504
[patent_app_country] => US
[patent_app_date] => 2001-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 74
[patent_no_of_words] => 52363
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20020192223.pdf
[firstpage_image] =>[orig_patent_app_number] => 09782504
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/782504 | Novel antibody conjugates reactive with human carcinomas | Feb 11, 2001 | Abandoned |
Array
(
[id] => 668644
[patent_doc_number] => 07094886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-22
[patent_title] => 'Evi27 gene sequences and protein encoded thereby'
[patent_app_type] => utility
[patent_app_number] => 09/778971
[patent_app_country] => US
[patent_app_date] => 2001-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 22
[patent_no_of_words] => 13118
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/094/07094886.pdf
[firstpage_image] =>[orig_patent_app_number] => 09778971
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/778971 | Evi27 gene sequences and protein encoded thereby | Feb 1, 2001 | Issued |
Array
(
[id] => 7432771
[patent_doc_number] => 20040002124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Cyr61 compositions and methods'
[patent_app_type] => new
[patent_app_number] => 10/182432
[patent_app_country] => US
[patent_app_date] => 2002-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 49728
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20040002124.pdf
[firstpage_image] =>[orig_patent_app_number] => 10182432
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/182432 | CYR61 compositions and methods | Jan 30, 2001 | Issued |
Array
(
[id] => 6876478
[patent_doc_number] => 20010006631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-05
[patent_title] => 'Treating tumors using implants comprising combinations of allogeneic cells'
[patent_app_type] => new-utility
[patent_app_number] => 09/771263
[patent_app_country] => US
[patent_app_date] => 2001-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21384
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20010006631.pdf
[firstpage_image] =>[orig_patent_app_number] => 09771263
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/771263 | Treating tumors using implants comprising combinations of allogeneic cells | Jan 25, 2001 | Issued |
Array
(
[id] => 7027813
[patent_doc_number] => 20010014328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-16
[patent_title] => 'Therapeutic multispecific compounds comprised of anti-Fcalpha receptor antibodies'
[patent_app_type] => new
[patent_app_number] => 09/772120
[patent_app_country] => US
[patent_app_date] => 2001-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 24179
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20010014328.pdf
[firstpage_image] =>[orig_patent_app_number] => 09772120
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/772120 | Therapeutic multispecific compounds comprised of anti-Fcalpha receptor antibodies | Jan 25, 2001 | Abandoned |
| 09/831744 | Phospholipase inhibitors for the treatment of cancer | Jan 24, 2001 | Abandoned |
Array
(
[id] => 6769517
[patent_doc_number] => 20030215457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Compositions and methods for treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 10/182033
[patent_app_country] => US
[patent_app_date] => 2002-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 44839
[patent_no_of_claims] => 100
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215457.pdf
[firstpage_image] =>[orig_patent_app_number] => 10182033
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/182033 | Compositions and methods for treatment of cancer | Jan 24, 2001 | Issued |
Array
(
[id] => 247194
[patent_doc_number] => 07585946
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-08
[patent_title] => 'Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions'
[patent_app_type] => utility
[patent_app_number] => 09/767370
[patent_app_country] => US
[patent_app_date] => 2001-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 10027
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/585/07585946.pdf
[firstpage_image] =>[orig_patent_app_number] => 09767370
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/767370 | Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions | Jan 22, 2001 | Issued |
Array
(
[id] => 6696361
[patent_doc_number] => 20030108555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-12
[patent_title] => 'Methods and compositions for cancer treatment'
[patent_app_type] => new
[patent_app_number] => 09/764224
[patent_app_country] => US
[patent_app_date] => 2001-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6309
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20030108555.pdf
[firstpage_image] =>[orig_patent_app_number] => 09764224
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/764224 | Composition for targeted cell treatment | Jan 15, 2001 | Issued |
Array
(
[id] => 1088872
[patent_doc_number] => 06828111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-07
[patent_title] => 'Three-dimensional in vitro model of human preneoplastic breast disease'
[patent_app_type] => B2
[patent_app_number] => 09/759365
[patent_app_country] => US
[patent_app_date] => 2001-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 69
[patent_no_of_words] => 20064
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/828/06828111.pdf
[firstpage_image] =>[orig_patent_app_number] => 09759365
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/759365 | Three-dimensional in vitro model of human preneoplastic breast disease | Jan 15, 2001 | Issued |
Array
(
[id] => 5905653
[patent_doc_number] => 20020142299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'PTD-modified proteins'
[patent_app_type] => new
[patent_app_number] => 09/757824
[patent_app_country] => US
[patent_app_date] => 2001-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11867
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20020142299.pdf
[firstpage_image] =>[orig_patent_app_number] => 09757824
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/757824 | PTD-modified proteins | Jan 8, 2001 | Abandoned |
| 09/601897 | NT-3 and medulloblastoma | Jan 4, 2001 | Abandoned |
Array
(
[id] => 7226660
[patent_doc_number] => 20040072993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Alpha (2) macroglobulin receptor as a heat shock protein receptor and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/750972
[patent_app_country] => US
[patent_app_date] => 2000-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 91
[patent_figures_cnt] => 91
[patent_no_of_words] => 40980
[patent_no_of_claims] => 96
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 09750972
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/750972 | α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof | Dec 27, 2000 | Issued |
Array
(
[id] => 6541404
[patent_doc_number] => 20020110538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Methods and products for tumor immunotherapy using cytokines'
[patent_app_type] => new
[patent_app_number] => 09/749649
[patent_app_country] => US
[patent_app_date] => 2000-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16527
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20020110538.pdf
[firstpage_image] =>[orig_patent_app_number] => 09749649
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/749649 | Methods and products for tumor immunotherapy using cytokines | Dec 26, 2000 | Abandoned |
Array
(
[id] => 6757710
[patent_doc_number] => 20030005487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Isolation and characterization of heat shock protein'
[patent_app_type] => new
[patent_app_number] => 09/742160
[patent_app_country] => US
[patent_app_date] => 2000-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 13295
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20030005487.pdf
[firstpage_image] =>[orig_patent_app_number] => 09742160
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/742160 | Isolation and characterization of heat shock protein | Dec 19, 2000 | Abandoned |
Array
(
[id] => 6095230
[patent_doc_number] => 20020051765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-02
[patent_title] => 'Method of cancer treatment'
[patent_app_type] => new
[patent_app_number] => 09/741503
[patent_app_country] => US
[patent_app_date] => 2000-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11057
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20020051765.pdf
[firstpage_image] =>[orig_patent_app_number] => 09741503
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/741503 | Method of cancer treatment | Dec 18, 2000 | Abandoned |